Publication: A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter
dc.contributor.author | Marco De Gobbi | en_US |
dc.contributor.author | Vip Viprakasit | en_US |
dc.contributor.author | Jim R. Hughes | en_US |
dc.contributor.author | Chris Fisher | en_US |
dc.contributor.author | Veronica J. Buckle | en_US |
dc.contributor.author | Helena Ayyub | en_US |
dc.contributor.author | Richard J. Gibbons | en_US |
dc.contributor.author | Douglas Vernimmen | en_US |
dc.contributor.author | Yuko Yoshinaga | en_US |
dc.contributor.author | Pieter De Jong | en_US |
dc.contributor.author | Jan Fang Cheng | en_US |
dc.contributor.author | Edward M. Rubin | en_US |
dc.contributor.author | William G. Wood | en_US |
dc.contributor.author | Don Bowden | en_US |
dc.contributor.author | Douglas R. Higgs | en_US |
dc.contributor.other | John Radcliffe Hospital | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Children's Hospital Oakland Research Institute | en_US |
dc.contributor.other | Lawrence Berkeley National Laboratory | en_US |
dc.contributor.other | Monash University | en_US |
dc.date.accessioned | 2018-08-20T07:28:20Z | |
dc.date.available | 2018-08-20T07:28:20Z | |
dc.date.issued | 2006-05-26 | en_US |
dc.description.abstract | We describe a pathogenetic mechanism underlying a variant form of the inherited blood disorder α thalassemia. Association studies of affected individuals from Melanesia localized the disease trait to the telomeric region of human chromosome 16, which includes the α-globin gene cluster, but no molecular defects were detected by conventional approaches. After resequencing and using a combination of chromatin immunoprecipitation and expression analysis on a tiled oligonucleotide array, we identified a gain-of-function regulatory single-nucleotide polymorphism (rSNP) in a non-genic region between the α-globin genes and their upstream regulatory elements. The rSNP creates a new promoterlike element that interferes with normal activation of all downstream α-like globin genes. Thus, our work illustrates a strategy for distinguishing between neutral and functionally important rSNPs, and it also identifies a pathogenetic mechanism that could potentially underlie other genetic diseases. | en_US |
dc.identifier.citation | Science. Vol.312, No.5777 (2006), 1215-1217 | en_US |
dc.identifier.doi | 10.1126/science.1126431 | en_US |
dc.identifier.issn | 10959203 | en_US |
dc.identifier.issn | 00368075 | en_US |
dc.identifier.other | 2-s2.0-33744475085 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/23950 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33744475085&origin=inward | en_US |
dc.subject | Multidisciplinary | en_US |
dc.title | A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33744475085&origin=inward | en_US |